Stocks · Health care · Pharmaceutical Preparations

Ovid Therapeutics Inc.

OVID Clue Score44
United States Fiscal year ends December CIK 0001636651 Results filed 18 Mar 2026

What the insiders did No buying or selling

By person

8 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Takeda Pharmaceutical Co Ltd entity
10% owner
—
—
—
7,000,000
$10.15M
+21.7%
Jeremy M Levin
Executive Chairman
—
—
—
3,735,048
$5.42M
+3.3%
Stelios Papadopoulos
Director
—
—
—
217,578
$315.49K
+8.8%
Jeffrey A Rona
Cbfo
—
—
—
156,313
$226.65K
+174.8%
Charles Ross Carter
Chief Financial Officer
—
—
—
94,375
$136.84K
+112.7%
Margaret A. Alexander
President and CEO
—
—
—
61,750
$89.54K
+119.6%
Kevin Joseph Fitzgerald
Director
—
—
—
17,578
$25.49K
—
Bart Friedman
Director
—
—
—
8,789
$12.74K
—

No percentages here. This company's share count has moved by a factor of 2.7 over the window, from 71,109,514 to 195,297,857 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.